Auri Knowledge

WHO WE ARE

Discover how safely we lead our customers through early stage product development research and fully customized in-vivo and in-vitro studies. View more

SUPPORTING SUCCESS

See how we monitor and support the planning and set-up of studies at an early stage. View more

SOLVING PROBLEMS

Experience how we always strive for the best solution, generating tailor-made products and services in drug research and testing. View more

EXPANDING THE RADIUS

Find out, why we consider ourselves as our clients extended arm in drug development, fast, efficient and interdisciplinary. View more

TURNKEY SOLUTIONS

Discover our turnkey preclinical package solutions being entirely customized to customer needs. View more

CLEARING THE PATH

Feel the dedication and passion for our customers.
Discover how our advisory team stands at their side on the way to future success. View more

SPEAKING SCIENCE

Explore our culture of direct communication in which scientist talk with scientists, from the first contact until the final document. View more

Aurigon News

19|03|22//Bio-Europe Spring 2019 in Vienna

We’re happy to attend the Bio-Europe Spring in Vienna! Visit us at the Bavarian International Pavillion (booth 28) and discuss your needs…

View more

19|03|12//SOT 2019

We’re happy to attend the annual meeting of Society of Toxicology in Baltimore! Visit us at booth 2009 and discuss…

View more

19|02|21//Renewed LinkedIn profile

The Aurigon Group proudly presents its renewed LinkedIn profile. Aurigon GmbH and ATRC Aurigon Ltd. has separate, but similar profiles…

View more

Science NEWS

19|04|05//New article co-authored by our colleague

The Aurigon Group proudly announce a new paper co-authored by our colleague, Tamas Kitka in his previous position. The article,…

View more

19|03|20//New booklet from EMA describing the route from research to marketing

The European Medicines Agency has recently published a wonderful and comprehensive booklet entitled “From laboratory to patient: the journey of…

View more

17|10|02//Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity

Source: Nature. By: Nobuyuki Tanaka, Shigeaki Kanatani [...] Peter Uhlén.  Intratumoral heterogeneity is a critical factor when diagnosing and treating patients with…

View more
Auri Knowledge